glp-1 agonist fda approval just approved orforglipron (Foundayo), Eli Lilly's oral receptor for obesity. In the ATTAIN-1 phase 3 trial (n=3,127), published in the New England Journal of Medicine, patients on the highest FDA Approves Oral Semaglutide: First

In this case, an anti-PD-1 could be considered for the treatment of type 1 diabetes

Acute presentation of dizziness in vitamin B12 deficient old patient of cardiac disease: a case report

On the way, we pass through La Raya, which is the border between the cities of Cusco and Puno at more than 4,335 m.s.l

Regulatory bodies are fast-tracking approvals for GLP-1s to address their growing health burden

Its sometimes added to topical ointments used to treat wounds for several reasons: It helps keep blood flowing more freely, can fight pain and swelling, forms L-proline, which is important for collagen synthesis within the skin, and increases antioxidant activity

Another clinical protocol used four consecutive intravenous injections that normalized disturbed sleep patterns, with effects lasting up to 20 hours and good compatibility when the peptide was injected slowly